Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells

B. Szende, Gordan Srkalovic, J. Tímár, Jeff J. Mulchahey, Jimmy D. Neill, K. Lapis, Andras Csikos, Karoly Szepeshazi, Andrew V. Schally

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Previous work showed that hamster and human pancreatic tumors but not normal pancreata exhibit low-affinity cell-membrane receptors for luteinizing hormone-releasing hormone (LHRH). Although the regression of experimental pancreatic cancers induced by treatment with LHRH agonists or antagonists could be explained in part by the creation of sex-steroid deficiency, direct effects mediated by LHRH receptors might also play a role. Here, we demonstrate that pancreatic tumor cells do exhibit high-affinity binding sites for LHRH, but only in their nuclei; low-affinity sites are associated with the cell membranes. These binding sites appear to be LHRH receptors since electron microscopic immunohistochemical studies show that an antibody to the LHRH receptor reacted with sites in the nucleus of pancreatic tumor cells. Immunoreactive sites in the nucleus also were found in a restricted set of normal hamster pituitary cells thought to be luteinizing hormone-secreting cells and in MXT mouse mammary tumor cells. Such nuclear receptors may be involved in the transmission of the direct action of LHRH analogues on the tumor cells, resulting in the enhancement of programmed cell death.

Original languageEnglish
Pages (from-to)4153-4156
Number of pages4
JournalProceedings of the National Academy of Sciences of the United States of America
Volume88
Issue number10
Publication statusPublished - May 15 1991

Fingerprint

LHRH Receptors
Pancreatic Neoplasms
Breast Neoplasms
Gonadotropin-Releasing Hormone
Cricetinae
Neoplasms
Binding Sites
Cell Membrane
Cytoplasmic and Nuclear Receptors
Luteinizing Hormone
Pancreas
Cell Death
Steroids
Electrons
Antibodies

Keywords

  • Apoptosis
  • Membrane receptors
  • Nuclear receptors
  • Peptide hormones

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells. / Szende, B.; Srkalovic, Gordan; Tímár, J.; Mulchahey, Jeff J.; Neill, Jimmy D.; Lapis, K.; Csikos, Andras; Szepeshazi, Karoly; Schally, Andrew V.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, No. 10, 15.05.1991, p. 4153-4156.

Research output: Contribution to journalArticle

Szende, B. ; Srkalovic, Gordan ; Tímár, J. ; Mulchahey, Jeff J. ; Neill, Jimmy D. ; Lapis, K. ; Csikos, Andras ; Szepeshazi, Karoly ; Schally, Andrew V. / Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells. In: Proceedings of the National Academy of Sciences of the United States of America. 1991 ; Vol. 88, No. 10. pp. 4153-4156.
@article{d1fa2271be464e0981acb40399e751e0,
title = "Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells",
abstract = "Previous work showed that hamster and human pancreatic tumors but not normal pancreata exhibit low-affinity cell-membrane receptors for luteinizing hormone-releasing hormone (LHRH). Although the regression of experimental pancreatic cancers induced by treatment with LHRH agonists or antagonists could be explained in part by the creation of sex-steroid deficiency, direct effects mediated by LHRH receptors might also play a role. Here, we demonstrate that pancreatic tumor cells do exhibit high-affinity binding sites for LHRH, but only in their nuclei; low-affinity sites are associated with the cell membranes. These binding sites appear to be LHRH receptors since electron microscopic immunohistochemical studies show that an antibody to the LHRH receptor reacted with sites in the nucleus of pancreatic tumor cells. Immunoreactive sites in the nucleus also were found in a restricted set of normal hamster pituitary cells thought to be luteinizing hormone-secreting cells and in MXT mouse mammary tumor cells. Such nuclear receptors may be involved in the transmission of the direct action of LHRH analogues on the tumor cells, resulting in the enhancement of programmed cell death.",
keywords = "Apoptosis, Membrane receptors, Nuclear receptors, Peptide hormones",
author = "B. Szende and Gordan Srkalovic and J. T{\'i}m{\'a}r and Mulchahey, {Jeff J.} and Neill, {Jimmy D.} and K. Lapis and Andras Csikos and Karoly Szepeshazi and Schally, {Andrew V.}",
year = "1991",
month = "5",
day = "15",
language = "English",
volume = "88",
pages = "4153--4156",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "10",

}

TY - JOUR

T1 - Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells

AU - Szende, B.

AU - Srkalovic, Gordan

AU - Tímár, J.

AU - Mulchahey, Jeff J.

AU - Neill, Jimmy D.

AU - Lapis, K.

AU - Csikos, Andras

AU - Szepeshazi, Karoly

AU - Schally, Andrew V.

PY - 1991/5/15

Y1 - 1991/5/15

N2 - Previous work showed that hamster and human pancreatic tumors but not normal pancreata exhibit low-affinity cell-membrane receptors for luteinizing hormone-releasing hormone (LHRH). Although the regression of experimental pancreatic cancers induced by treatment with LHRH agonists or antagonists could be explained in part by the creation of sex-steroid deficiency, direct effects mediated by LHRH receptors might also play a role. Here, we demonstrate that pancreatic tumor cells do exhibit high-affinity binding sites for LHRH, but only in their nuclei; low-affinity sites are associated with the cell membranes. These binding sites appear to be LHRH receptors since electron microscopic immunohistochemical studies show that an antibody to the LHRH receptor reacted with sites in the nucleus of pancreatic tumor cells. Immunoreactive sites in the nucleus also were found in a restricted set of normal hamster pituitary cells thought to be luteinizing hormone-secreting cells and in MXT mouse mammary tumor cells. Such nuclear receptors may be involved in the transmission of the direct action of LHRH analogues on the tumor cells, resulting in the enhancement of programmed cell death.

AB - Previous work showed that hamster and human pancreatic tumors but not normal pancreata exhibit low-affinity cell-membrane receptors for luteinizing hormone-releasing hormone (LHRH). Although the regression of experimental pancreatic cancers induced by treatment with LHRH agonists or antagonists could be explained in part by the creation of sex-steroid deficiency, direct effects mediated by LHRH receptors might also play a role. Here, we demonstrate that pancreatic tumor cells do exhibit high-affinity binding sites for LHRH, but only in their nuclei; low-affinity sites are associated with the cell membranes. These binding sites appear to be LHRH receptors since electron microscopic immunohistochemical studies show that an antibody to the LHRH receptor reacted with sites in the nucleus of pancreatic tumor cells. Immunoreactive sites in the nucleus also were found in a restricted set of normal hamster pituitary cells thought to be luteinizing hormone-secreting cells and in MXT mouse mammary tumor cells. Such nuclear receptors may be involved in the transmission of the direct action of LHRH analogues on the tumor cells, resulting in the enhancement of programmed cell death.

KW - Apoptosis

KW - Membrane receptors

KW - Nuclear receptors

KW - Peptide hormones

UR - http://www.scopus.com/inward/record.url?scp=0025828537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025828537&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 4153

EP - 4156

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 10

ER -